Stay updated on Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a prominent operating-status notice and a new software version (v3.2.0), replacing the old version tag v3.1.0. This signals potential delays in data processing and updated status information.SummaryDifference2%
- Check19 days agoChange DetectedUpdate location name from Blankenfelde to Blankenfelde-Mahlow and bump revision from v3.0.2 to v3.1.0.SummaryDifference0.3%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated to v3.0.2 and Back to Top removed; no core content or critical information is affected.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has undergone significant updates, including the addition of numerous location entries across various countries and the removal of outdated location references. Notably, the facility name and specific locations have been clarified and expanded.SummaryDifference10%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.